Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980
- PMID: 1335975
Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980
Abstract
Alterations in sympathetic nervous system (SNS) activity are widely believed to contribute to the pathophysiology of the obese state. Disagreement, however, exists as to whether the predominant sympathetic abnormality is a decrease in neuronal activity (leading to diminished sympathetically-mediated energy expenditure and weight gain) or an increase (leading to hypertension). Findings summarized from over 40 separate studies support both hypotheses as well as the alternative thesis that SNS activity does not differ in obese humans compared to lean controls. Another abnormality being noted with increasing frequency in human obesity is reduced adrenaline (Ad) levels in plasma, both at rest or in response to a stimulus such as physical activity. Whether diminished adrenal medullary function is a cause or consequence of the obese state and whether the adrenal medulla plays any role in the regulation of energy metabolism on a daily basis are not known at the present time. Thus, while depressed SNS activity may be a sufficient explanation for the development of obesity, it is not a necessary condition. Suppressed adrenal medullary function may also contribute to this disorder.
Similar articles
-
Pathophysiology of obesity-related hypertension: role of insulin and the sympathetic nervous system.J Cardiovasc Pharmacol. 1994;23 Suppl 1:S1-8. J Cardiovasc Pharmacol. 1994. PMID: 7519690 Review.
-
The effect of diet or exercise on plasma norepinephrine kinetics in moderately obese young men.Int J Obes. 1990 Jan;14(1):1-11. Int J Obes. 1990. PMID: 2179146 Review.
-
Impaired glucose-induced thermogenesis and arterial norepinephrine response persist after weight reduction in obese humans.Am J Clin Nutr. 1990 Mar;51(3):331-7. doi: 10.1093/ajcn/51.3.331. Am J Clin Nutr. 1990. PMID: 2178388
-
Sympathoadrenal activity and obesity: physiological rationale for the use of adrenergic thermogenic drugs.Int J Obes Relat Metab Disord. 1993 Feb;17 Suppl 1:S29-34. Int J Obes Relat Metab Disord. 1993. PMID: 8384176 Review.
-
Sympathetic system activity in obesity and metabolic syndrome.Ann N Y Acad Sci. 2006 Nov;1083:129-52. doi: 10.1196/annals.1367.010. Ann N Y Acad Sci. 2006. PMID: 17148737 Review.
Cited by
-
Impaired sympathoadrenal axis function contributes to enhanced insulin secretion in prediabetic obese rats.Exp Diabetes Res. 2011;2011:947917. doi: 10.1155/2011/947917. Epub 2011 Aug 16. Exp Diabetes Res. 2011. PMID: 21860615 Free PMC article.
-
Association of Visceral Adipose Tissue With Hypertension: Results From the NHANES 2011-2018 and Mendelian Randomization Analyses.J Clin Hypertens (Greenwich). 2025 Jan;27(1):e14953. doi: 10.1111/jch.14953. Epub 2024 Dec 10. J Clin Hypertens (Greenwich). 2025. PMID: 39654488 Free PMC article.
-
The clinical biochemistry of obesity.Clin Biochem Rev. 2004 Aug;25(3):165-81. Clin Biochem Rev. 2004. PMID: 18458706 Free PMC article.
-
The global epidemic of obesity: are we becoming more sympathetic?Curr Hypertens Rep. 2004 Jun;6(3):241-6. doi: 10.1007/s11906-004-0076-7. Curr Hypertens Rep. 2004. PMID: 15128479 Review.
-
Blunted Peripheral and Central Responses to Gastric Mechanical and Electrical Stimulations in Diet-induced Obese Rats.J Neurogastroenterol Motil. 2013 Oct;19(4):454-66. doi: 10.5056/jnm.2013.19.4.454. Epub 2013 Oct 7. J Neurogastroenterol Motil. 2013. PMID: 24199005 Free PMC article.